The Canadian pension fund CDPQ is co-investing alongside EQT in the acquisition of French nursing home operator Colisée, its second investment in the European healthcare sector.
UK-based CARE Fertility has acquired Nuffield Health's Woking Assisted Conception Scheme, its third acquisition since being acquired by Silverfleet Capital.
HBI's analysis of Italy's largest for-profit hospital operator San Donato Group's accounts answers many questions about the group's financial health before COVID. Like: which hospital accounts for 40% of revenues yet drags down profits by 20%? How concentrated is the business in its Milan stronghold and does this differ for profitability? Which subsidiaries are growing and which aren't?
Shares in Finnish outsourcing specialist Pihlajalinna have crashed 25% on the news that the Finnish Competition and Consumer Authority (FCCA) has recommended that the country's Market Court block its takeover by CVC-backed competitor Mehilainen.
Brazilian listed HMOs (health management organisations) Hapvida Saude and Grupo Notre Dame Intermedica have resumed their M&A binge since July after a quiet second quarter, despite the pandemic continuing to rage throughout the country.
An investigation has found that kickbacks are still rife in the Nigerian diagnostics market with some of the market's players artificially hiking prices so as to retain the extra costs.
Sell-side advisors Perella Weinburg have shortlisted a dozen second-rounder bidders for Eugin, the global IVF arm of NMC Health, according to reports in Spain. A source tells HBI Eugin's recent figures have been significantly impacted by COVID - will it impact the valuation?
August activity levels for France's second-largest hospital group Elsan were ahead of 2019, while Italy's largest player San Donato is still 30% down due to a more gradual restart of electives and stricter contagion control in Lombardy, HBI can reveal. The cautiousness reflects just how hard-hit the region was.
UK hospital group Spire Healthcare became a majority NHS-funded provider for the first time ever during the first half of 2020 as it became an extension of the public health system, its H1 2020 results reveal. What are the implications and how do you value a company in such unprecedented circumstances? We talk to an analyst.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
